Table 1.
Clinical features of 10 sarcoidosis patients
| No. | Patient (age, years/sex) | Cutaneous lesions | Chest lesions | Eye | Other lesions | PPD reaction | ACE (7·7–29·4 U/l) |
|---|---|---|---|---|---|---|---|
| 1 | 54/F | Nodular/SI | NR | NR | Nerve | ND | 9·8 |
| 2 | 50/F | Plaque/SI | NR | Uveitis | NR | Positive | 14·4 |
| 3 | 63/F | Nodular/SI | BHL/lung | Uveitis | NR | Negative | 33·8 |
| 4 | 67/F | Plaque/SI | BHL | NR | NR | Negative | 33·0 |
| 5 | 26/M | SI | BHL | NR | NR | Negative | 18·3 |
| 6 | 47/F | Plaque/SI | BHL | NR | NR | ND | 30·3 |
| 7 | 71/M | Nodular | NR | Uveitis | Lymph node | ND | 12·7 |
| 8 | 66/M | SI | BHL/lung | NR | NR | Negative | 15·8 |
| 9 | 36/M | Nodular/subcutaneous | NR | NR | Nerve | ND | 19·8 |
| 10 | 55/F | SI | BHL/lung | NR | Lymph node | Negative | 24·4 |
SI: scar infiltrates; NR: normal; BHL: bilateral hilar lymphadenopathy; ND: not done; ACE: angiotensin converting enzyme.